2016
DOI: 10.1016/j.bbrc.2016.05.062
|View full text |Cite
|
Sign up to set email alerts
|

Production, characterization, and in vitro effects of a novel monoclonal antibody against Mig-7

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 14 publications
0
1
0
Order By: Relevance
“…VE-cadherin was downregulated significantly on both RNA and protein levels. Clinical use of novel, targeted therapies including angiogenesis inhibitors has revealed new features of malignant ovarian tumors and important cancer molecular pathways checkpoints like MIG-7 activation that could be blocked with monoclonal antibodies [30].…”
Section: Discussionmentioning
confidence: 99%
“…VE-cadherin was downregulated significantly on both RNA and protein levels. Clinical use of novel, targeted therapies including angiogenesis inhibitors has revealed new features of malignant ovarian tumors and important cancer molecular pathways checkpoints like MIG-7 activation that could be blocked with monoclonal antibodies [30].…”
Section: Discussionmentioning
confidence: 99%
“…Mig-7 significantly affects tumor migration and invasion in hepatocellular carcinoma and osteosarcoma, while it is essential for proliferation and invasion in ovarian cancer [8,9]. Further, Mig-7 is overexpressed in highly invasive tumors but not in non-invasive malignant cells [10][11][12][13], suggesting an important role in tumor invasion. Additionally, knocking down Mig-7 attenuates the invasiveness of U87MG cells [12].…”
mentioning
confidence: 99%